Gene Therapy reimbursed for SMA patients in Czechia
By controluser
Czech Health Insurance companies recently approved reimbursement of breakthrough gene therapy treatment for …
By controluser
Czech Health Insurance companies recently approved reimbursement of breakthrough gene therapy treatment for …
By controluser
April 8, 2020 EURORDIS open letter to policy makers: Recommendations to protect people …
By controluser
April 1, 2020 The company ExCEEd Orphan announces its consulting cooperation expansion with …
By controluser
AveXis receives positive CHMP opinion for Zolgensma®, the only gene therapy for spinal …
By controluser
Novartis receives approval from Japanese Ministry of Health, Labour and Welfare for Zolgensma® …
By controluser
ExCEEd Orphan is honoured and engaged to support Rare Disease Day campaign and …
By controluser
The company ExCEEd Orphan announces its consulting cooperation with Kyowa Kirin (https://www.kyowakirin.com/) in …
By controluser
ExCEEd Orphan announces a further consulting cooperation with Akcea Therapeutics in the CEE …
By controluser
AveXis receives FDA approval for Zolgensma®, the first and only gene therapy for …